Chemicals & Advanced Materials Global On demand · 24-48h

Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Strategic Research Report

Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market
$93.062025
13.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: PLGA 50: 50, PLGA 75: 25, PLGA 90: 10, Others

By Application: Surgical, Drug Sustained Release, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Evonik, Seqens, Corbion, Mitsui Chemicals, Nomisma Healthcare, eSUNMED, Jinan Daigang Biomaterial, Shenzhen Polymtek Biomaterial

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 105 pages
Market size 2025
$93.06
Million USD
Forecast CAGR
13.3%
2025-2032
Forecast 2032
$223
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Medical Poly (lactic-co-glycolic acid) (PLGA) market size is predicted to grow from US$ 93.06 million in 2025 to US$ 220 million in 2032; it is expected to grow at a CAGR of 13.3% from 2026 to 2032.

Medical is one of the most successfully developed biodegradable polymers. PLGA, PLG, or poly(lactic-co-glycolic acid) (CAS: 26780-50-7 ) is a copolymer which is used in a host of Food and Drug Administration (FDA) approved therapeutic devices, owing to its biodegradability and biocompatibility.

Medical Poly (lactic-co-glycolic acid) (PLGA) is a biodegradable copolymer widely used in drug delivery, tissue engineering, and medical devices due to its excellent biocompatibility and tunable degradation rate. It is a preferred material for producing microspheres, nanoparticles, absorbable sutures, and bone repair scaffolds. With the advancement of precision medicine and regenerative therapies, demand for PLGA is rapidly increasing. The growing elderly population and rise in chronic diseases globally drive the need for innovative drug delivery systems and implantable materials, boosting the PLGA market. Particularly, emerging markets in the Asia-Pacific region, including China and India, contribute significantly to growth due to increased healthcare investments. Future PLGA developments will focus on higher molecular weights, customization, and composite materials to meet complex clinical needs.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Poly (lactic-co-glycolic acid) (PLGA) market?

What factors are driving Medical Poly (lactic-co-glycolic acid) (PLGA) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Poly (lactic-co-glycolic acid) (PLGA) market opportunities vary by end market size?

How does Medical Poly (lactic-co-glycolic acid) (PLGA) break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Poly (lactic-co-glycolic acid) (PLGA) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • PLGA 50: 50
  • PLGA 75: 25
  • PLGA 90: 10
  • Others

Segment by Application

  • Surgical
  • Drug Sustained Release
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Poly (lactic-co-glycolic acid) (PLGA) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Surgical, Drug Sustained Release, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 13.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$93.06
2025
Forecast
$223
2032
CAGR
13.3%
2025–2032
Regionen
5
global
Key companies
EvonikSeqensCorbionMitsui ChemicalsNomisma HealthcareeSUNMEDJinan Daigang BiomaterialShenzhen Polymtek Biomaterial
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PLGA 50: 50PLGA 75: 25PLGA 90: 10Others
By Application
SurgicalDrug Sustained ReleaseOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 PLGA 50: 50
  • 3.1.3 PLGA 75: 25
  • 3.1.4 PLGA 90: 10
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Surgical
  • 4.1.3 Drug Sustained Release
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Evonik
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Seqens
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Corbion
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Mitsui Chemicals
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Nomisma Healthcare
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 eSUNMED
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Jinan Daigang Biomaterial
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shenzhen Polymtek Biomaterial
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Medical Poly (lactic-co-glycolic acid) (PLGA) market?
The global Medical Poly (lactic-co-glycolic acid) (PLGA) market is estimated at US$ 93.06 million in 2025 (base year) and is projected to reach US$ 220 million by 2032.
What is the forecast CAGR for the Medical Poly (lactic-co-glycolic acid) (PLGA) market?
The market is expected to grow at a CAGR of 13.3% from 2026 to 2032, expanding from US$ 93.06 million in 2025 to US$ 220 million in 2032, roughly 2.4 times its base-year value.
What is Medical Poly (lactic-co-glycolic acid) (PLGA)?
Medical is one of the most successfully developed biodegradable polymers. PLGA, PLG, or poly(lactic-co-glycolic acid) (CAS: 26780-50-7 ) is a copolymer which is used in a host of Food and Drug Administration (FDA) approved therapeutic devices, owing to its biodegradability and biocompatibility.
How is the Medical Poly (lactic-co-glycolic acid) (PLGA) market segmented by type?
By type, the market is segmented into PLGA 50: 50, PLGA 75: 25, PLGA 90: 10 and Others.
What are the key applications of Medical Poly (lactic-co-glycolic acid) (PLGA)?
Key applications covered include Surgical, Drug Sustained Release and Others.
Which companies are profiled in the Medical Poly (lactic-co-glycolic acid) (PLGA) market report?
Key players profiled include Evonik, Seqens, Corbion, Mitsui Chemicals, Nomisma Healthcare, eSUNMED, Jinan Daigang Biomaterial and Shenzhen Polymtek Biomaterial.
What geographies does the Medical Poly (lactic-co-glycolic acid) (PLGA) market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Medical Poly (lactic-co-glycolic acid) (PLGA)?
What factors are driving Medical Poly (lactic-co-glycolic acid) (PLGA) market growth, globally and by region?
Who should buy the Medical Poly (lactic-co-glycolic acid) (PLGA) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Surgical, Drug Sustained Release and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Poly (lactic-co-glycolic acid) (PLGA) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.